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Summary
The demographic and clinical characteristics of adults and children with lower extremity deep-
vein thrombosis and/or pulmonary embolism (LE DVT/PE) may differ from those with abdominal 
vein thrombosis (abdominal VT). Abdominal VT can be a presenting sign of an underlying 
prothrombotic state, and its presence in the setting of known disease might have prognostic 
implications different from LE DVT/PE. This study describes clinical presentations of abdominal 
VT compared to LE DVT/PE in adults and children. We analysed prospectively-collected data 
from consecutive consenting patients enrolled in one of seven Centers for Disease Control and 
Prevention (CDC) funded Thrombosis and Hemostasis Network Centers from August 2003 to 
April 2011 to compare the demographic and clinical characteristics of adults and children with 
abdominal VT. Both adults and children with abdominal VT tended to be younger and have a 
lower body mass index (BMI) than those with LE DVT/PE. Of patients with abdominal VT, 
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children were more likely to have inferior vena cava (IVC) thrombosis than adults. For adults with 
venous thromboembolism (VTE), relatively more women had abdominal VT than LE DVT/PE, 
while the proportions with LE DVT/PE and abdominal VT by sex were similar in children. 
Children with abdominal VT were more likely to have diagnosed inherited thrombophilia, while 
trauma was more common in children with LE DVT/PE. In conclusion, both children and adults 
with abdominal VT were younger with a lower BMI than those with LE DVT/PE. Significant 
differences exist between children and adults in respect to abdominal VT compared to LE 
DVT/PE.
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Introduction
With more children living with chronic disease and with an increase in vascular procedures 
and indwelling catheters, the incidence of venous thromboembolism (VTE) in paediatric 
patients is increasing (1–4). In adults, VTE continues to be a major cause of morbidity, and 
its incidence in older women might be increasing (5). As with adults, the most common 
types of VTE in children are lower extremity deep-vein thrombosis (LE DVT) and 
pulmonary embolism (PE).
While less common than LE DVT/PE, abdominal vein thrombosis (abdominal VT) is a 
significant cause of morbidity in children and adults. Furthermore, abdominal VT can be a 
presenting sign of an underlying prothrombotic state, and its presence in the setting of 
known disease might have prognostic implications different from LE DVT/PE (6). 
Compared with LE DVT/PE, abdominal VT is not described well in the literature, 
particularly in children, where (the incidence is comparatively low. Paediatric providers and 
researchers often rely on data from adults to inform management decisions. Especially in the 
setting of abdominal VT, this approach is inadequate and could be improved through 
characterisation of adult and paediatric VTE as distinct clinical entities.
Children have different risk factors and locations of VTE compared with adults. Overall, 
90% of paediatric patients who develop a VTE have an acquired or congenital risk factor for 
thrombosis, compared to about 60% for adults (3, 7). A common acquired risk factor for 
VTE in children is an indwelling central venous line (CVL), which has previously been 
reported in 33–59% of all paediatric cases and 80–97% of neonates with VTE (8, 9). In 
addition to CVLs, sepsis, antiphospholipid antibodies, malignancy, and trauma are also 
common acquired VTE risk factors in children.
Using data compiled from the Centers for Disease Control and Prevention (CDC)-funded 
U.S. Thrombosis and Hemostasis Centres Program from 2003–2011, we compared the 
demographic and clinical characteristics of adults and children with common VTE 
presentations, namely LE DVT or PE (LE DVT/PE), to those with abdominal vein 
thrombosis (abdominal VT) (i.e. thrombosis of hepatic, portal, splenic, mesenteric or renal 
veins, or inferior vena cava [IVC]). Our aim was to assess how abdominal VT differs from 
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LE DVT/PE overall and among adults and children separately. Understanding differences in 
risk factors for less common presentations of VTE, including children and patients with 
abdominal VT, is important for developing age-specific prevention and management 
strategies. Patients with abdominal VT seem to present differently than those with LE 
DVT/PE, and the presenting characteristics, mechanisms of disease, and prognostic 
implications for children with VTE differ from those of adults. Ultimately, an overall lack of 
data on paediatric VTE, specifically abdominal VT, motivated this study. This report 
presents an analysis of VTE patients participating in this multi-site registry.
Materials and methods
Study setting, population, and design
We conducted this cross-sectional study across seven centres within the CDC-funded 
thrombosis and Hemostasis Centers Research and Prevention Network (the University of 
Michigan Hemophilia and Coagulation Disorders Program, Ann Arbor, MI, USA; the 
Thrombophilia Program, UNC, Chapel Hill, NC, USA; the Michigan State University 
Comprehensive Centre for Bleeding Disorders, East Lansing, MI, USA; the Wayne State 
University, Detroit, MI, USA; the Mountain States Regional Hemophilia and Thrombosis 
Centre, Aurora, CO, USA; the Duke Hemostasis and Thrombosis Program, Durham, NC, 
USA; UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, USA). The 
Thrombosis and Hemostasis Network Centers have been described previously (10).
Demographic and clinical characteristics were prospectively collected from consecutive 
consenting thrombosis and thrombophilia patients enrolled within one of seven Thrombosis 
and Haemostasis Centres over the nine-year period, from August 2003 to April 2011 using a 
standardised data-collection form. Many patients were referred to one of the seven centres 
by local providers for further evaluation and management of thrombotic disease, and most 
were seen as outpatients. This report presents an analysis of VTE patients participating in 
this multi-site registry.
Patients and/or their families attending one of the seven centres for medical care, or seen as 
an inpatient consult or referral, were approached by local centre staff for participation in a 
multi-site patient registry, regardless of age, gender, or race. For paediatric patients, consent 
was obtained from the parent or legal guardian as well as an assent for children older than 
seven years of age.
For consenting patients, data were collected at the initial and all subsequent visits and 
entered into a web-based registry maintained on a secure server within the Division of Blood 
Disorders at the CDC. Patient identifying information, including name, address, physician, 
and insurance carrier, remained within a locally housed secure database at each centre. For 
purposes of confidentiality, only the study identification number and registry information 
were sent to the registry at the CDC. The registry, study protocol, and other study materials 
are approved annually by the Institutional Review Hoards at each of the participating sites 
and at the CDC.
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Inclusion and exclusion criteria
Utilising the Network’s patient registry, we identified patients with a history of abdominal 
VT and LE DVT/PE enrolled as of April 2011. Patients with a history of thrombosis 
Involving any of the hepatic, portal, mesenteric, renal, splenic, ovarian, and penile veins, or 
in the IVC were defined to have abdominal VT. Patients with a history of diagnosed VTE 
occurring only as lower extremity DVT and/or PE, i.e. no VTE in any other location at any 
time, comprised the comparison LE DVT/PE group. Lower extremity DVT and abdominal 
VT were considered objectively diagnosed when symptoms or signs of acute thrombus were 
present, and the diagnosis was confirmed by venography, compression venous duplex 
ultrasonography, impedance plethysmography, computed tomographic (CT) venography, or 
magnetic resonance imaging (MRI). Symptoms included pain, swelling, or sometimes 
evidence of organ dysfunction, as with renal vein thrombosis. A PE was considered 
objectively diagnosed when symptoms and/or signs of acute PE were present, and the 
diagnosis was confirmed by pulmonary angiography, a ventilation/perfusion lung scan 
interpreted as high probability for PE, CT pulmonary angiography, or MRI. Patients enrolled 
in the registry who did not meet the abdominal VT or LE DVT/PE definitions were 
excluded.
Measurements
Data collected for the registry included patient demographic and clinical characteristics, 
referral patterns, reasons for and details of the visit including providers seen, laboratory and 
radiological tests ordered, educational materials received, comorbidities, and treatments 
prescribed. To assess age-specific characteristics, the two age groups were further stratified 
by age at enrollment into paediatric (age <21 years) and adult (age ≥21 years) subgroups.
Definition of variables
The presence of medical comorbidities was defined as the patient having the condition 
within the three months prior to the VTE event. The presence of thrombophilia was defined 
by diagnosis of an inherited or acquired thrombophilia (factor V Leiden, prothrombin 
20210A mutation, antiphospholipid syndrome, anti-thrombin, protein C or protein S 
deficiency) at enrollment or after subsequent evaluation by a CDC Thrombosis and 
Haemostasis Research and Prevention Network Centre. For patients with antiphospholipid 
antibodies and for many with an inherited thrombophilia, the presence of thrombophilia was 
confirmed by laboratory testing performed at the participating Centre, and the decision to 
test was at the discretion of the Network provider. The updated Sapporo criteria (11) were 
used for diagnosis of antiphospholipid syndrome. When assessing the prevalence of VTE 
complications, we restricted our analyses to those patients with sufficient time after their 
initial event for the complication to occur. Thus, we defined patients with multiple VTE as 
patients with more than one VTE occurring at least one month apart, and post-thrombotic 
syndrome (PTS) was assessed in patients at least 12 months after their initial presentation.
Analyses
The prevalence of a priori identified patient demographic and clinical characteristics for 
abdominal VT and LE DVT/PE were compared overall and separately among children and 
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adults. For categorical variables, univariate frequencies were generated and compared using 
Pearson’s chi-square and two-tailed p-values, and in the case of small cell sizes (<5), two-
tailed Fisher’s exact p-values are reported. For the continuous variables of age at first VTE 
and body mass index (BMI), the mean and median values were computed, and differences 
were tested for statistical significance using Student’s t-test and the Wilcoxon sign rank test, 
respectively. To assess the risk for abdominal VT compared to LE DVT/PE, unadjusted 
odds ratios (OR) and 95% confidence intervals (CI) were computed for those demographic 
and clinical characteristics that met the p=0.05 significance level among the paediatric and 
adult subgroups. Multiple logistic regression analysis was used lo generate adjusted OR and 
associated 95% CI and Wald p-values. To compare the prevalence of VTE complications 
between the two VTE groups, the proportion of patients who developed multiple VTE (VTE 
at least one month apart) and post-thrombotic syndrome (PTS) were calculated and 
compared overall and by age strata using Pearson’s chi-square and two-tailed p-values.
The distance from patient residence to Network centre was compared between patients with 
abdominal VT and LE DVT/PE to better characterise the patient population. Distances 
represent miles from the centroid of the home residence zip code to the centroid of the 
Centre’s zip code. Mean distance was calculated and then compared between the groups 
using Student’s t-test. All analyses were performed using SAS 9.2 (SAS Institute Cary, NC, 
USA).
Results
As of April 2011, the patient registry contained a total of 3,466 patients with VTE, of whom 
466 were children. Among these, 55 children (11.8%) and 240 adults (8.0%) had abdominal 
VT, while 236 children (50.6%) and 2,308 adults (76.9%) met the criteria for the LE 
DVT/PE comparison group.
Presenting characteristics for patients with abdominal VT differed between paediatric and 
adult patients. Paediatric patients with abdominal VT were more likely to have IVC 
thrombus (25 of 55; 45.5%) than adults (40 of 240; 16.7%; p<0.0001). Conversely, 
paediatric patients were less likely to have hepatic, portal, and mesenteric thrombosis (n=35; 
63.6%) than adults (n=205; 85.4%, p<0.0002). Five patients in each age group had 
abdominal VT involving the IVC and another abdominal vein.
There was no relationship between sex and location of VTE overall and among children, 
with equal proportions of boys and girls having abdominal VT and LE DVT/PE (Table 1). 
However, among adults, the abdominal VT group had more females than the LE DVT/PE 
group (67% vs. 60%; p=0.03; Table 1).
The demographics of patients experiencing abdominal VT differed from those experiencing 
LE DVT/PE overall and by age. Overall, patients who develop abdominal VT tend to 
develop their first VTE earlier than those who developed LE DVT/PE (p<0.0001; ▶Figure 
1). Most children with VTE were 13 years or older; however, among both adult and 
paediatric patients, the mean age at first VTE for patients having abdominal VT was lower 
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than that of patients having LE DVT/PE (▶Table 1). Of the six neonates (<28 days) 
identified for the analysis, five had abdominal VT.
Similar to age, the mean and median body mass index (at enrollment) was lower for patients 
having abdominal VT than for patients having LE DVT/PE for both children and adults 
(Table 1). There was no difference by race between the two VTE groups overall. However, 
paediatric patients with abdominal VT were more likely to be of Hispanic ethnicity 
compared to paediatric patients with LE DVT/PE (25.5% vs. 10.2%; p=0.002). This 
relationship was not found in adults (▶Table 1).
Clinical characteristics also differed between the two VTE groups by age. Adults with 
abdominal VT had a higher prevalence of recent surgery, recent catheter, chronic renal and 
liver disease, and autoimmune conditions compared to the adult LE DVT/PE group (▶Table 
2). Some reported autoimmune conditions included lupus, multiple sclerosis, rheumatoid 
arthritis, hypothyroidism, Bechet’s disease, Addison’s disease, sarcoidosis, and 
inflammatory bowel disease. Only two paediatric patients (3.6%) and eight adult patients 
(3.3%) with abdominal VT had a CVL. Only the relationship with autoimmune conditions 
was seen in the paediatric patients, but trauma was more frequently seen in paediatric 
patients with LE DVT/PE than abdominal VT (11% vs. 2%, p=0.03; ▶Table 2).
The prevalence of inherited thrombophilia or antibody syndrome (APS) did not differ 
between adults with abdominal VT compared to those with LE DVT/PE. However, children 
with abdominal VT were more likely to have a diagnosed thrombophilia (p=0.05) compared 
with children with lower extremity LE DVT/PE (▶Table 2). In particular, protein C 
deficiency and prothrombin 20210A were more commonly identified in children with 
abdominal VT than LE DVT/PE (p=0.003 and p=0.05, respectively). Adjusted OR for these 
risk factors are calculated and given in ▶Table 3.
Among adults, recent surgery, chronic renal disease, chronic liver disease, and recent 
catheter, were all found to be independent risk factors for abdominal VT compared to LE 
DVT/PE (▶Table 3). While older age and higher BMI were associated with LE DVT/PE. 
Similar to adults, older age was a risk for LE DVT/PE among the paediatric group, but other 
associations differed. Presence of autoimmune conditions and protein C deficiency were the 
only independent risk factors for abdominal VT in those under age 21 (▶Table 3).
Among females at least 13 years old, we did not find any difference in the use of oral 
contraceptives (OCs), hormone replacement therapies (HRTs), history of adverse pregnancy 
outcomes, or pregnancy-related VTE between those who had abdominal VT compared those 
with LE DVT/PE overall or by age.
The prevalence of additional VTE did not differ by VTE type or age (data not shown). 
Seventy-two adult (30.0%) and eight paediatric patients (15.4%) with abdominal VT had 
another VTE, among whom 41 developed a LE DVT/PE after their abdominal VT (34 DVT 
and 7 PE). The prevalence of post-thrombotic syndrome (PTS) did not differ between the 
adults or children with abdominal VT compared to those with LE DVT/PE. However, 
children with abdominal VT had a higher prevalence of PTS compared to adults with 
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abdominal VT (17.7% vs. 7.8%; p=0.02). Conversely, children with LE DVT/PE were less 
likely to develop PTS than adults with LE DVT/PE (6.4% vs. 9.7%; p=0.05).
The mean distance to a referral centre was greater for adults with abdominal VT compared 
to LE DVT/PE (83.7 miles vs. 46.9 miles; p=0.04), but this relationship was not seen in 
children (50.9 miles vs. 56.1 miles; p=0.66).
Discussion
The study found several significant differences in patient characteristics and outcomes 
between abdominal VT and LE DVT/PE in children and adults: Both adult and paediatric 
patients with abdominal VT tended to be younger and have a lower BMI than patients with 
LE DVT/PE. Only six neonates (<1 month old) were included in the study, of whom five 
had abdominal VT. However, even outside of the neonatal period, children with abdominal 
VT were younger than those with LE DVT/PE. In our study, adult females with VTE were 
more likely to have abdominal involvement than males, and adults with abdominal VT were 
more likely to have hepatic, portal and/or mesenteric vein thrombosis, and common co-
morbid conditions included recent surgery and autoimmune disorders. While, paediatric 
patients with abdominal VT in our study were more evenly divided between male and 
female, more commonly had IVC thrombosis, and co-morbid conditions, they were less 
likely to include recent trauma, in addition, children with abdominal VT were more likely to 
have an inherited thrombophilia, specifically protein C deficiency, compared to children 
with LE DVT/PE. Beth adult and paediatric patients with abdominal VT exhibited a high 
prevalence of multiple VTE events.
In a previous report, neonatal and pre-adolescent males and females have had similar 
incidences of VTE, while teenage girls were twice as likely as boys to develop VTE (12). In 
our study population, there was no gender predominance in paediatric patients, and there 
were relatively few patients <21 years old with pregnancy-related VTE. There were no 
pregnancy-related episodes of abdominal VT in children, and only eleven of 236 cases of LE 
DVT/PE in children were pregnancy-related. Our age cut-off of 21 years old reflects a 
general separation between paediatric and adult providers, but it is possible that pregnant 
adolescents are also managed by obstetricians, who could have different referral patterns 
compared to other paediatric providers.
Although the presence of a CVL is a common modifiable risk factor for VTE, only a small 
minority of the children and adults in our study had a CVL. This is almost certainly due to 
referral bias. Patients with modifiable risk factors, such as a CVL, or those with a disease 
commonly complicated by VTE (perhaps including pregnancy) may be less likely to be 
referred to one of the centres. Conversely, the registry contained a large proportion of VTE 
in patients with non-modifiable risk factors, such as antiphospholipid antibodies or inherited 
thrombophilia.
By comparing the distances travelled by patients seen at one of the seven CDC centres, we 
sought to explore referral patterns and perhaps gauge local providers’ level of comfort in 
managing common VTE compared to more unusual presentations of VTE. While there was 
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no difference in distance to referral centre for children with abdominal VT vs. LE DVT/PE, 
adults with abdominal VT tended to come from greater distances than adults with LE 
DVT/PE. This discrepancy could stem from adult providers managing LE DVT/PE locally, 
whereas paediatric patients with any VTE could be more likely to be referred.
We found that children with abdominal VT were much more likely to have an inherited 
thrombophilia or antiphospholipid syndrome compared to children with LE DVT/PE, 
although not all patients were tested for thrombophilia which limits the interpretation of 
these data. Overall, the absolute risk for VTE in children heterozygous for a thrombophilia 
mutation is small; one large prospective study in patients with heterozygous protein C, 
protein S, antithrombin, and prothrombin gene defects found negligible rates of VTE in 
children <15 years of age (13). However, a large meta-analysis of observational studies 
showed a significant link between inherited thrombophilia mutations and first onset of VTE, 
with highest OR in patients with multiple thrombophilic traits or who had antithrombin, 
protein C, or protein S deficiencies (14). Again, we suspect that patients with non-
modifiable risk factors were more likely to be referred to one of the centres.
We also found a large frequency of children had multiple VTE with both abdominal VT 
(15.4%) and LE DVT/PE (11.6%). Young et al. reported that 95% at children without a 
known acquired risk factor who developed recurrent VTE had at least one inherited risk 
factor, and 47% had two genetic risk factors (14). The overall recurrence risk for DVT in 
children has been estimated at 4–13% (2, 8, 14–17), and the higher frequency of multiple 
events in our population might stem from an increased proportion of patients with non-
modifiable risk factors.
Adult data have shown that the cumulative incidence of VTE recurrence increases with 
follow-up duration (18), and this is almost certainly true for children as well. In a large 
German registry, the risk of recurrence in children who had no acquired risk factor on initial 
presentation at a median seven years of follow-up was reported to be about 21% (19).
Children with abdominal VT or LE DVT/PE were also more likely to have antiphospholipid 
antibodies when tested than adults with abdominal VT or LE DVT/PE, respectively. 
Previous studies have reported a positive lupus anticoagulant in about 25% of children with 
VTE (4); approximately 16% of paediatric patients in our study met diagnostic criteria for 
antiphospholipid syndrome.
Post-thrombotic syndrome (PTS) is a common cause of morbidity after DVT and consists of 
venous insufficiency, swelling, and pain occurring after VTE. Reports of PTS in children 
vary widely, with incidences reported between 9% (20) and 70% (3) of children with VTE 
outside the neonatal period. We found that children were more likely than adults to develop 
PTS following abdominal VT. The prevalence of PTS in children with abdominal VT in our 
study was 14.6% compared to 4.2% of children with lower extremity DVT/PE. Data from 
the Canadian registry at a median follow-up of 2 years showed 9% of children had 
developed PTS (20). Therefore it is important for providers to be cognisant of the high risk 
for PTS in children with abdominal VT since prompt initiation of anticoagulation therapy 
seems to reduce the risk for developing PTS in children (21) as well as adults (22).
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Although this study contains a large number of children and adults with a history of 
abdominal VT, the population studied may not be representative of all children and adults 
with VTE because of the potential for referral bias. Most patients were seen as outpatients, 
and a larger proportion of patients in the registry had a non-modifiable risk factor compared 
with VTE patients in the general population. We expect that the common presentations of 
VTE, especially those in the setting of modifiable risk factors, would be less likely to be 
referred to one of the Haemostasis and Thrombosis Centres. We chose 21 years of age for a 
cut-off between paediatric and adult patients but recognise variability exists on this topic in 
the literature. A central aim of our study was to compare presenting characteristics of 
abdominal VT vs. LE DVT/PE in children and adults to help inform patient care and 
management. VTE is a complex disease in which maturity of the coagulation system, 
presence of underlying disease or other risk factors, and medical environment of the patient 
interact. While our study contained a large proportion of patients with non-modifiable risk 
factors, the increasing incidence of paediatric VTE is likely driven by children with 
underlying medical disease living longer. These patients are often followed by paediatric 
specialists and have modifiable risk factors different from those in older adults.
Conclusions
The multi-site design of the CDC Thrombosis and Haemostasis Centres Network registry 
provides a means to compile robust data on both paediatric and adult VTE. Particularly, the 
Network’s enrollment of a large number of children with abdominal VT in the multi-site 
patient registry make it useful for comparing risk factors and characteristics in children with 
these variables to adults with similar clinical events. However, since the Centres are all large 
referral centres, the data collected in the registry may not be representative of all VTE 
patients.
Abdominal VT is a significant cause of morbidity and may be a harbinger of disease or have 
prognostic implications. Presenting characteristics differ between patients with abdominal 
VT compared to those with LE DVT/PE. The presence of abdominal VT, particularly in 
children, should trigger clinicians to investigate for thrombophilia, and following these 
patients prospectively, especially in the setting of non-modifiable risk factors for VTE, is 
important for elucidating prognostic information. Continued reports on the presentations and 
subsequent courses of abdominal VT and LE DVT/PE in children are needed to develop 
screening and treatment guidelines.
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What is known about this topic?
• Compared with lower extremity deep-vein thrombosis (DVT)/pulmonary 
embolism (PE), abdominal vein thrombosis (abdominal VT) is less common in 
children and adults.
• Characteristics of children with venous thromboembolism (VTE) differ from 
those of adults.
• Characteristics between patients with lower extremity DVT/PE likely differ 
from those with abdominal VT
What does this paper add?
• We report data compiled from a large number of children and adults with VTE 
in a well-powered study investigating characteristics of patients with abdominal 
VT.
• We report significant differences in clinical and demographic characteristics 
between children and adults with abdominal VT compared to those with lower 
extremity DVT/PE.
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Distribution of age at first VTE occurrence among patients with abdominal VT and LE 
DVT/PE. Chi-square. p<0.0001; p for trend= <0.0001; Data not collected an 52 patients.
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Table 3
Unadjusted and adjusted OR for risk factors for abdominal VT in adults (age ≥ 21) and paediatric patients (age 
< 21).
Age ≥ 21 Unadjusted OR (95% CI) Adjusted* OR (95%CI) Wald p-value
Female sex 1.37 (1.03, 1.81) 1.36 (0.99, 1.86) 0.06
Hispanic 1.89 (0.95, 3.76) 1.65 (0.79, 3.47) 0.18
Age first VTE 0.98 (0.9, 0.99) 0.98 (0.97, 0.99) <0.0001
BMI 0.96 (0.94, 0.98) 0.96 (0.94, 0.98) <0.0001
Surgery 1.70 (1.15, 2.51) 1.55 (1.02, 2.37) 0.04
Chronic renal disease 5.79 (2.7, 12.3) 4.04 (1.69, 9.70) 0.002
Chronic liver disease 2.07 (1.2, 3.7) 2.02 (1.09, 3.75) 0.03
Central venous line 2.07 (3.10, 20.3) 4.39 (1.60, 12.11) 0.004
Autoimmune conditions 1.70 (1.21, 2.39) 1.42 (0.98, 2.05) 0.07
Age < 21 Unadjusted OR (95% % CI) Adjusted* OR (95%CI) Wald p-value
Hispanic ethnicity 3.02 (1.44, 6.32) 2.30 (0.97, 5.41) 0.06
Age at first VTE 0.91 (0.87, 0.95) 0.92 (0.87, 0.97) 0.003
BMI 0.93 (0.88, 0.98) 0.97 (0.92, 1.03) 0.30
Trauma/Injury 0.15 (0.02, 1.13) 0.17 (0.02, 1.38) 0.10
Autoimmune conditions 2.98 (1.10, 8.90) 4.45 (1.47, 13.51) 0.008
Prothrombin 20210A 3.27 (1.0, 10.7) 2.45 (0.62, 9.67) 0.20
Protein C deficiency 11.70 (2.2, 62.0) 13.4 (2.29, 78.7) 0.004
*
Adjusted for all other listed variables.
BMI, body mass index CI, confidence interval; OR, odds ratio; VTE, venous thromboembolism.
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